Status:
COMPLETED
Stepped Care Treatment for Binge-Eating
Lead Sponsor:
Temple University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Binge Eating Disorder
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
Temple University is looking for women to participate in a study to evaluate the treatment options available to women living with binge eating disorder. Binge-Eating Disorder is a significant public ...
Eligibility Criteria
Inclusion
- Adult female, 18 years to 60 years
- Meets DSM-IV criteria for Binge Eating Disorder
- Resides within commuting distance
- Consents to research protocol, i.e.
- 18-24 months in assessment and treatment
- willing to be part of a biological assessment/physiological assessment
- have to be prepared that they will receive a brief individual treatment and if this does not work for them, that they will receive more intensive treatment including both group and individual treatment.
- agreement not to see other health professionals unless recommended
- seeing their own Primary care Physician/Nurse Practitioner for medical screening prior to study (i.e., before being allocated a guided self-help therapist)
- payment for their own medical assessment, monitoring, and medication if needed
Exclusion
- Anorexia nervosa
- Schizophrenia, Schizophreniform, or Schizoaffective Disorders, Psychosis NOS, or Bipolar Mood Disorder
- Needs priority treatment for other debilitating conditions, e.g. current substance dependence requiring inpatient detox
- chronic absence of shelter
- IQ less than 70
- Impending jail/prison, court order to treatment, court order to treatment or to jail, or agency order to treatment or to loss of child custody (due to consequent inability to freely drop-out of treatment)
- Is pregnant, plans to become pregnant during treatment, or becomes pregnant before random assignment to study condition
- Medical instability
- Has had or is seeking Gastric bypass surgery
- On anti-seizure medication, beta-blockers, asthma medication, medication for heart disease, or any other medication that affects appetite or weight
- Psychotropics are acceptable if the doses are stable for at least 3 months prior to screening
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2017
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT00965705
Start Date
June 1 2009
End Date
March 1 2017
Last Update
April 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Temple University
Philadelphia, Pennsylvania, United States, 19122